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PPsychological Distress as a
Risk Factor for Cardiovascular Events
Pathophysiological and Behavioral Mechanisms
Mark Hamer, PHD, Gerard J. Molloy, PHD, Emmanuel Stamatakis, PHD
London, United Kingdom
Objectives This study sought to estimate the extent to which behavioral and pathophysiological risk factors account for the
association between psychological distress and incident cardiovascular events.
Background The intermediate processes through which psychological distress increases the risk of cardiovascular disease
(CVD) are incompletely understood. An understanding of these processes is important for treating psychological
distress in an attempt to reduce CVD risk.
Methods In a prospective study of 6,576 healthy men and women (ages 50.9  13.1 years), we measured psychological
distress (using the 12-item version of the General Health Questionnaire 4) and behavioral (smoking, alcohol,
physical activity) and pathophysiological (C-reactive protein, fibrinogen, total and high-density lipoprotein choles-
terol, obesity, hypertension) risk factors at baseline. The main outcome was CVD events (hospitalization for non-
fatal myocardial infarction, coronary artery bypass, angioplasty, stroke, heart failure, and CVD-related mortality).
Results Cigarette smoking, physical activity, alcohol intake, C-reactive protein, and hypertension were independently as-
sociated with psychological distress. There were 223 incident CVD events (63 fatal) over an average follow-up of
7.2 years. The risk of CVD increased in relation to presence of psychological distress in age- and sex-adjusted
models (hazard ratio: 1.54, 95% confidence interval: 1.09 to 2.18, p  0.013). In models that were adjusted for
potential mediators, behavioral factors explained the largest proportion of variance (65%), whereas pathophys-
iological factors accounted for a modest amount (C-reactive protein 5.5%, hypertension, 13%).
Conclusions The association between psychological distress and CVD risk is largely explained by behavioral processes. There-
fore, treatment of psychological distress that aims to reduce CVD risk should primarily focus on health behavior
change. (J Am Coll Cardiol 2008;52:2156–62) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.08.057a
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rhe link between psychosocial stress and cardiovascular
isease (CVD) has been identified as an important public
ealth issue (1). The presence of psychological distress,
easured with screening instruments such as the General
ealth Questionnaire, has been associated with incident
VD in several prospective cohort studies (2–5), with effect
izes that are comparable to conventional risk factors such as
ypertension, obesity, and physical inactivity (6). The value
f treating psychological distress using a range of modalities
as therefore been an area of considerable interest and
ntense debate in clinical and research work in CVD (7).
rom the Department of Epidemiology and Public Health, University College,
ondon, United Kingdom. Drs. Hamer and Molloy receive grant funding from the
ritish Heart Foundation, United Kingdom. Dr. Stamatakis receives grant funding
rom the National Institute for Health Research, United Kingdom. The Scottish
ealth Survey is funded by the Scottish Executive. The views expressed in this article
re those of the authors and not necessarily of the funding bodies.c
Manuscript received April 30, 2008; revised manuscript received July 23, 2008,
ccepted August 26, 2008.Although the association between psychological distress
nd CVD risk is well established, the intermediate mecha-
isms are yet to be fully elucidated. Behavioral changes,
uch as increased smoking, reduced physical activity, and
oor dietary habits may occur as an adaptation or coping
esponse to psychological distress, thus are potentially im-
ortant intermediate factors in disease processes (8). Psy-
See page 2163
hosocial stress primarily activates the hypothalamic pitu-
tary adrenocortical axis and sympathetic nervous system,
hich can trigger pathophysiological mechanisms that in-
lude inflammation, hemostasis, and altered metabolic and
ardiac autonomic control (1). The behavioral and patho-
hysiological processes that operate between psychological
istress and CVD events provide the key to understanding
nd treating psychological distress that aims to reduce CVD
isk. These variables can be thought of as the “causes of the
ause” in clinical and research work that starts with the
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n CVD risk.
Because the mediating variables are many and varied, it is
mportant that the relative contribution of behavioral and
athophysiological processes in accounting for the distress–
VD link be reliably established. This is particularly necessary
iven the very different treatment modalities that follow from
greater emphasis on either class of process, for example,
ehavior change and pharmacotherapy. These data would help
stablish priorities for the allocation of health care and research
esources. To date, few studies have compared behavioral and
athophysiological processes in this way. Recent data from the
ritish Whitehall II cohort have shown that traditional and
ovel CVD risk markers did not account for any of the
ssociation between psychological distress and incident coro-
ary heart disease (CHD) (9). However, given that the results
rom this occupational cohort cannot be generalized to the
ider population, it is important that this type of study is
eplicated in large, representative, community-based samples
f asymptomatic adults, because the results will have far-
eaching implications for public health efforts to reduce the
isease burden of CVD associated with psychological distress.
We analyzed data from the Scottish Health Survey (SHS)
o address the following questions: 1) how much of the
ssociation between psychological distress and CVD events
an be explained by behavioral and pathophysiological
rocesses; and 2) what is the relative contribution of
ehavioral and pathophysiological processes in explaining
he link?
ethods
articipants and study design. The SHS is a periodic
urvey (typically every 3 to 5 years) that draws a nationally
epresentative sample of the general population living in
ouseholds. The sample was drawn using multistage strat-
fied probability sampling with postcode sectors selected at
he first stage and household addresses selected at the
econd stage. Different samples were drawn for each survey.
he present analyses combined data from the 1998 and
003 SHS in adults age 30 years and older. Participants
rom the different survey years were comparable in terms of
emographics and risk factors. The overall response rate
anged between 60% and 76% for the different survey years,
ith approximately 63% of all eligible participants seeing a
urse. Participants gave full informed consent to participate
n the study, and ethical approval was obtained from the
ondon Research Ethics Council. Participants who de-
lined the nurse visit or did not consent to blood being taken
ere excluded from the analyses (n  4,776). Participants
ith existing CVD were also removed from the analyses
n  156), leaving a final sample size of 6,576 (44.9% men,
ges 50.9  13.1 years). Excluded participants generally
howed poorer health risk profiles with higher body mass
ndex and a greater prevalence of hypertension, CVD,
moking, and psychological distress. saseline assessment. Survey in-
erviewers visited eligible house-
olds and collected data on de-
ographics, height, weight, and
ealth behaviors (physical activ-
ty, smoking, alcohol intake).
hysical activity questions in-
uired about participation in the
weeks before the interview.
requency, duration, and inten-
ity of participation was assessed
cross 3 domains of activity: lei-
ure time sports (e.g., cycling,
wimming, running, aerobics,
ancing, and ball sports such as
ootball and tennis), walking for
ny purpose, and domestic phys-
cal activity (e.g., heavy house-
ork, home improvement activ-
ties, and manual and gardening
ork). The physical activity
uestionnaire has been validated against the output of
ccelerometers (worn for 2 nonconsecutive weeks over a
-month period in 106 British adults). On a separate visit,
urses collected information on medical history, waist cir-
umference, and blood samples from consenting adults.
etailed information on the survey method can be found
lsewhere (10).
redictor and outcome variables. Current mental health
as assessed from the 12-item version of the General
ealth Questionnaire (GHQ-12), which is a measure of
sychological distress devised for population studies. The
uestionnaire comprises 12 questions, asking informants
bout their general level of happiness, experience of depres-
ive and anxiety symptoms, and sleep disturbance over the
ast 4 weeks. Interpretation of the answers is based on a
-point response scale scored using a bimodal method
symptom present: not at all  0, same as usual  0, more
han usual  1, much more than usual  1). The GHQ-12
s a highly validated instrument and has been strongly
ssociated with various psychological disorders such as
epression and anxiety (11). In the present sample, the
HQ-12 showed good internal reliability (Cronbach  
.896). We used a score of 4 to define psychological
istress according to studies validating the GHQ-12 against
tandardized psychiatric interviews (12). In addition, we
sed the GHQ-12 score as a continuous variable to examine
inear relationships with CVD events.
The main outcome was fatal or nonfatal cardiovascular
vents (including myocardial infarction [MI], coronary ar-
ery bypass, percutaneous coronary angioplasty, stroke, heart
ailure). This information was obtained from a patient-
ased database of CVD hospital admissions and deaths
Information Services Division Scotland) that was linked to
he surveys. The Information Services Division database has
Abbreviations
and Acronyms
CHD  coronary heart
disease
CI  confidence interval
CRP  C-reactive protein
CV  coefficient of
variation
CVD  cardiovascular
disease
GHQ-12  12-item version
of the General Health
Questionnaire
HDL  high-density
lipoprotein
HR  hazard ratio
MI  myocardial infarction
SHS  Scottish Health
Surveyhown 94% accuracy and 99% completeness when samples
o
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Psychological Distress and CVD December 16/23, 2008:2156–62f computerized CVD records from the Scottish national
atabase were compared with the original patient case notes.
ortality from cardiovascular causes was coded according to
nternational Classification of Diseases Version 9 (390–
59) and the International Classification of Diseases Ver-
ion 10 (I01–I99). Data on CVD hospital admissions were
vailable between 1980 and September 2006, which allowed
s to exclude participants with existing CVD at baseline.
iological risk markers. Peripheral blood was collected in
itrate and serum tubes and spun at room temperature. All
lood samples were frozen at 70°C until assay. The
nalysis of C-reactive protein (CRP) levels from serum was
erformed using the N Latex high-sensitivity CRP mono
mmunoassay on the Dade Behring Nephelometer II ana-
yzer (Deerfield, Illinois). The limit of detection was 0.17
g/l, and the coefficient of variation (CV) was6% for this
ssay. Fibrinogen levels were determined using the Organon
eknika MDA 180 analyzer (Durham, North Carolina),
sing a modification of the Clauss thrombin clotting
ethod, with a CV of 10%. Cholesterol and high-density
ipoprotein (HDL) cholesterol were measured using choles-
erol oxidase assays on an Olympus Diagnostics 640 ana-
yzer (Tokyo, Japan). All analyses were carried out in the
ame laboratory according to standard operating procedures
y state-registered Medical Laboratory Scientific Officers.
xisting hypertension was confirmed from self-reported
octor’s diagnosis. Obesity was defined as a body mass index
30 kg/m2 and central obesity as waist 102 cm in men
nd 88 cm in women.
tatistical methods. Cox proportional hazards models were
sed with months as the time scale to estimate the risk of
ardiovascular events according to psychological distress. The
ata were censored to September 2006 in participants who
urvived. The proportional hazards assumption was examined
y comparing the cumulative hazard plots grouped on expo-
ure, although no appreciable violations were noted. In the
asic multivariate model, we adjusted for potential confounders
ncluding age and sex. To test the extent to which behavioral
nd pathophysiological risk factors account for the association
etween psychological distress and CVD events, we grouped
ogether CVD risk factors considered to be potential mediators
n an a priori basis. This included behavioral factors (physical
ctivity, smoking, alcohol), an inflammatory/hemostatic factor
CRP and fibrinogen), a metabolic factor (adiposity measures,
holesterol, HDL cholesterol), and a blood pressure factor
doctor-diagnosed hypertension). We initially adjusted for
ehaviors and then added pathophysiological factors into the
odel. The proportion of CVD risk reduction explained by
ach set of factors was estimated as follows: (HRbasic model 
Radjusted)/HRbasic model  1)  100 (13), where HR 
azard ratio. Health behaviors were entered as categorical
ariables: physical activity was categorized into 5 groups
ccording to frequency of any activity lasting at least 30 min
reference group no activity, 1/week, 1 to 2/week, 3 to
/week, 5/week); smoking was categorized into 4 groups
reference group never smoked, occasional ex-smokers, fegular ex-smokers, current smokers); alcohol intake was
uantified in units per week (1 U  one-half pint of beer, a
mall glass of wine, or a measure of spirits) and categorized
nto 3 sex-specific groups with nondrinkers assigned to the
eference group and the highest intake group representing
nsafe drinking levels (14 U for women/21 U for men).
ll blood variables were entered as categorical variables;
holesterol, HDL cholesterol, and fibrinogen as tertiles and
RP was categorized according to previously defined cut
oints (14), representing low-risk (1 mg/l), medium-risk
1 to 3 mg/l), and high-risk (3 mg/l) groups. Analyses
ere also run entering risk markers as continuous values,
lthough this did not appreciably alter the results. We used
nalysis of variance tests to examine continuous variables
nd chi-square tests to examine univariable relationships of
he confounders with the exposure measure. We also per-
ormed multivariate logistic regression analyses to determine
ndependent associations between the potential mediators
nd psychological distress. All analyses were performed
sing SPSS (version 14, SPSS Inc., Chicago, Illinois), and
ll tests of statistical significance were based on 2-sided
robability.
esults
here were a total of 223 incident CVD events (63 fatal)
ver an average of 7.2 years of follow-up; CHD accounted
or 62% of nonfatal events (n  58 nonfatal MI, n  15
oronary artery bypass graft, n  26 percutaneous coronary
ngioplasty) and 66% of fatal CVD events. At baseline,
4.6% of participants showed psychological distress. Dis-
ressed participants were slightly younger, and were more
ikely to be female, to have poorer health behaviors, and to
ave higher levels of inflammatory and hemostatic markers
nd a greater prevalence of hypertension (Table 1). In
ultivariate analyses, age, sex, cigarette smoking, physical
ctivity, alcohol intake, CRP, and hypertension remained
ignificantly associated with psychological distress (Table 2).
hese factors were therefore retained for inclusion as
otential mediators in modeling the association between
sychological distress and incident CVD.
Psychologically distressed participants (GHQ-12 4)
ere at a higher relative risk of CVD events during
ollow-up (Table 3). There was also a linear relationship
etween GHQ-12 score and CVD events, with each stan-
ard deviation (2.7) increment in GHQ-12 score being
ssociated with a 7% increased risk (age- and sex-adjusted
azard ratio [HR]: 1.07, 95% confidence interval [CI]: 1.03
o 1.12, p  0.002). The addition of potential mediators
ubstantially attenuated the association between psycholog-
cal distress and risk of CVD events, with all factors
ollectively explaining an estimated 83.3% of the variance.
hen behavioral factors were modeled separately, smoking
ccounted for 40.7%, physical activity 22.3%, and alcohol
2% of the variance. The addition of pathophysiologicalactors accounted for a further modest proportion of the
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hen hypertension and CRP were modeled separately,
5.2% of the variance was explained (HR: 1.35, 95% CI:
.96 to 1.91), although they accounted for only 18.5% of the
ariance after prior adjustment for behavioral risk factors.
In further analyses that were stratified by age and sex,
here were similar effects of distress on CVD among men
nd women, although the effects were weaker in older
articipants (65 years old) (HR: 1.32, 95% CI: 0.72 to
.44, p  0.372) compared with younger adults (HR: 1.63,
5% CI: 1.07 to 2.47, p  0.023).
Several of the mediating factors were independently associ-
ted with CVD events, which included HDL cholesterol1.5
mol/l (HR: 0.66, 95%CI: 0.47 to 0.94, p 0.022), CRP3
g/l (HR: 1.71, 95%CI: 1.09 to 2.68, p 0.02), hypertension
HR: 2.07, 95% CI: 1.56 to 2.75, p  0.001), smoking (HR:
.51, 95% CI: 1.76 to 3.59, p 0.001), and moderate physical
ctivity levels (HR: 0.47, 95% CI: 0.29 to 0.76, p  0.003).
There were a total of 247 deaths during follow-up, and
here was a relationship between risk of all-cause mortality
nd psychological distress (HR: 1.88, 95% CI: 1.39 to 2.54)
n models adjusted for age, sex, and social economic group.
djustments for behavioral and pathophysiological risk
actors significantly attenuated the association (HR: 1.36,
5% CI: 1.00 to 1.85), collectively explaining 59%.
iscussion
he present investigation confirms the results of previous
tudies that have shown a robust relationship between
sychological distress and CVD risk (2–5). We observed
imilar associations between men and women, although
eaker associations in older participants (65 years old),
hich might reflect a greater presence of other age-related
VD risk factors that attenuate the effects of psychological
Descriptive Characteristics of Participants at B
Table 1 Descriptive Characteristics of Parti
Variable
No Distress GHQ-12
(n  5,618)
Age, yrs 50.6 13.2
Men, % 46.4
Social class, % grade I/II 33.9
Current smokers, % 27.2
Alcohol, U/week
Men 16.8 20.6
Women 5.9 8.1
Sedentary, % 20.9
Obese (30 kg/m2), % 20.8
Central obesity, % 29.1
Total cholesterol, mmol/l 5.74 1.16
HDL cholesterol, mmol/l 1.49 0.42
C-reactive protein, mg/l 3.29 6.21
Fibrinogen, mg/l 2.90 0.71
Hypertension, % 15.6
Values are mean  SD, unless indicated otherwise.
GHQ-12  12-item version of the General Health Questionnaire; HDistress. The main aim of the present study was to estimate ahe extent to which behavioral and pathophysiological
actors explain the association between psychological dis-
ress and CVD events, which has not been widely examined.
ur data suggest that the behavioral factors of smoking and
hysical activity made the largest contribution to increased
isk, with CRP and hypertension making a modest contri-
ution. Interestingly, pathophysiological factors accounted
or a considerably lower proportion of the variance after
rior adjustment for behavioral risk factors, which might
eflect shared variance between these variables. For example,
e have recently shown that in the present sample of
articipants, inflammation and hemostasis are associated
ith multiple modifiable CVD risk factors, including phys-
cal activity, smoking, obesity, and hypertension (15).
Psychological distress was associated with a higher prev-
lence of hypertension that partly mediated the greater risk
f CVD events. Previous work suggests that anger, anxiety,
nd depression are predictors of hypertension (16), and
cute psychological trauma such as terrorist attacks and
arthquakes can produce profound and sustained increases
n blood pressure (17,18). Because hypertension is a potent
isk factor for CVD, it is therefore plausible that the
ssociation between psychological distress and CVD is
artly mediated through this risk factor. To our knowledge
here are a limited number of studies that have examined the
ole of novel biomarkers in accounting for the distress–
VD relationship. Data from the Whitehall II cohort
uggested that inflammatory markers did not explain any of
he association between psychological distress and incident
HD (9). Other studies that have directly measured de-
ressive symptoms, one of the components of the GHQ-12,
re also equivocal. For example, inflammatory markers
CRP and interleukin-6) and the metabolic syndrome
xplained approximately 17% and 7%, respectively, of the
e by Psychological Distress
ts at Baseline by Psychological Distress
Distressed GHQ-12 >4
(n  959) p Value
49.3 14.5 0.004
36.2 0.001
31.3 0.02
43.1 0.001
20.6 29.1 0.02
7.6 13.6 0.004
36.3 0.001
22.8 0.02
29.4 0.446
5.70 1.08 0.283
1.51 0.47 0.214
4.73 9.10 0.001
2.98 0.81 0.001
21.6 0.001
h-density lipoprotein.aselin
cipan
<4ssociation between depression and CVD events in women
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Psychological Distress and CVD December 16/23, 2008:2156–62ith suspected coronary ischemia (19,20). And, in a previ-
us case control study, various inflammatory markers did
ot explain any of the association between depressive
ymptoms and risk of CHD (21). Experimental research,
owever, underlines the effects of acute psychosocial stress
n inflammatory responses (22), and these responses may be
mplified by the presence of chronic psychosocial stress (23)
nd depressive symptoms (24). Acute stress also has been
hown to activate nuclear factor kappa B in peripheral
lood mononuclear cells and gene expression and protein
roduction of several inflammatory cytokines that is
ependent on stimulation of the sympathetic nervous
ystem (25–27). The reliability of different measures may
xplain why behavior seemed to account for a consider-
bly larger amount of the association between distress
Multivariate Logistic Regression to Examine theof Psychological Distress With Behavioral and P
Table 2 Multivariate Logistic Regression toof Psychological Distress With Beh
Predictor Variable Cases/Tota
Age (yrs)
30–44 4
45–64 4
65 1
Sex
Male 3
Female 6
Total physical activity (frequency per week)
None 3
1 1
1–2 1
3–4 1
5 1
Smoking status
Never smoked 3
Previous light smoker
Previous regular smoker 2
Current smoker 4
Alcohol
Never 2
Moderate 4
More than recommended limit 2
Obesity (BMI 30 kg/m2)
No 7
Yes 2
C-reactive protein (mg/l)
1 2
1 to 3 3
3 3
Fibrinogen tertiles
Bottom 3
Middle 3
Top 3
Hypertension
No 7
Yes 2
The OR wasmutually adjusted for each of the presented variables, plus
and HDL cholesterol.
BMI  body mass index; CI  confidence interval; OR  odds rationd CVD risk than biological factors. That is, biological wactors measured from the blood, such as inflammatory
arkers, are generally estimated from a single sample
hat may be subject to considerable measurement error
nd may not reflect chronic levels.
Although the effectiveness of behavioral change and
sychological stress reduction has been established clearly in
asic research, the evidence to support the efficacy of such
nterventions that aim to prevent cardiovascular events is
imited (7). In one of the largest trials of 2,481 MI patients
uffering from depression and low perceived social support,
reatment with cognitive behavior therapy had no effect on
vent-free survival after 29 months of follow-up despite
ignificant improvement in depression and perceived social
upport (28). However, in a secondary analysis, self-
eported exercise in the 6 months after MI was associated
ociationphysiological Risk Factors
ine the Association
l and Pathophysiological Risk Factors
959/6,576) OR (95% CI) of GHQ-12 >4 p Value
62 1.00
67 0.77 (0.65–0.91) 0.002
48 0.47 (0.37–0.61) 0.001
52 1.00
25 1.61 (1.36–1.89) 0.001
22 1.00
8 0.49 (0.38–0.62) 0.001
16 0.50 (0.40–0.61) 0.001
71 0.45 (0.36–0.56) 0.001
70 0.37 (0.30–0.46) 0.001
03 1.00
0 0.97 (0.63–1.48) 0.878
91 1.19 (0.98–1.45) 0.077
43 1.94 (1.63–2.30) 0.001
36 1.00
57 0.72 (0.60–0.86) 0.001
84 1.02 (0.82–1.28) 0.852
87 1.00
90 1.11 (0.88–1.39) 0.393
01 1.00
70 1.07 (0.89–1.29) 0.459
06 1.31 (1.06–1.62) 0.012
77 1.00
88 1.03 (0.86–1.24) 0.731
12 0.89 (0.73–1.10) 0.281
92 1.00
85 1.53 (1.27–1.84) 0.001
nal adjustment for social economic group, central obesity, cholesterol,
bbreviations as in Table 1.Assatho
Exam
aviora
l (N 
03/2,5
22/2,8
34/1,1
47/2,9
12/3,6
48/1,5
05/79
77/1,3
47/1,1
82/1,7
17/2,8
27/24
02/1,5
13/1,9
59/1,4
79/3,8
21/1,2
40/5,1
19/1,3
93/2,3
12/2,2
54/2,0
02/2,2
26/2,1
31/2,1
52/5,4
07/1,0
additioith more than a 50% reduction in the risk of subsequent
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December 16/23, 2008:2156–62 Psychological Distress and CVDeath (29). Other recent data suggest that aggressive lipid
owering can minimize the increased risk of atherosclerotic
rogression in patients with depressive symptoms (30).
hese data therefore indicate that treating the intermediate
rocesses, such as health behaviors and pathophysiological
actors, is a key aspect of reducing distress-related CVD
isk. Further research, however, is required to establish
hether physical activity or inactivity, alcohol abuse, and
moking are more accurately conceived of as a set of
epressogenic or anxiogenic behaviors or representative of
he behavioral phenotype of individuals genetically predis-
osed to depression or anxiety.
Several limitations of the present study warrant consid-
ration. We have assessed psychological distress only once at
aseline, thus we cannot exclude the possibility that changes
n distress over time could have influenced our results.
dditionally, because the GHQ-12 was administered at the
ame time point as the measurement of behavioral and
athophysiological factors, we cannot establish the precise
ature of the temporal relationship between these factors.
or example, recent evidence suggests a bidirectional asso-
iation between inflammation and depression (31,32). Nev-
rtheless, our analysis supports the main criteria for medi-
tion, that is, psychological distress was associated with
ehavioral and pathophysiological risk factors (potential
ediators), the potential mediators predicted incident
VD, and psychological distress predicted incident CVD;
his association was significantly attenuated after adjustment
or the mediators. The GHQ-12 is a robust indicator of
eneral psychological distress at a population level, although
t cannot be used to distinguish the specific nature of the
he Extent to Which Behavioral andathophysiol gical Risk Factorsxplain the Association Between Psychologicalistress and CVD Events
Table 3
The Extent to Which Behavioral and
Pathophysiological Risk Factors
Explain the Association Between Psychological
Distress and CVD Events
Model
No Distress
GHQ-12 <4
Distressed
GHQ-12 >4 p Value
Cases/N 183/5,618 40/959
Age- and sex-adjusted
HR (95% CI) 1.00 1.54 (1.09–2.18) 0.013
Model 1
HR (95% CI) 1.00 1.32 (0.93–1.87) 0.116
Model 2
HR (95% CI) 1.00 1.20 (0.84–1.70) 0.317
Model 3
HR (95% CI) 1.00 1.19 (0.84–1.69) 0.328
Model 4
HR (95% CI) 1.00 1.12 (0.79–1.59) 0.533
Model 5
HR (95% CI) 1.00 1.09 (0.77–1.56) 0.614
odel 1 was adjusted for age, sex, and cigarette smoking. Model 2 was adjusted for age, sex,
igarette smoking, and physical activity. Model 3 was adjusted for age, sex, cigarette smoking,
hysical activity, and alcohol intake. Model 4 was adjusted for age, sex, cigarette smoking, physical
ctivity, alcohol intake, and hypertension. Model 5 was adjusted for age, sex, cigarette smoking,
hysical activity, alcohol intake, hypertension, and CRP.
Abbreviations as in Tables 1 and 2.istress. The present results should therefore be interpretedith caution when making comparisons with studies that
ave directly assessed depression using standardized meth-
ds, and it will be necessary to replicate and extend our
ndings using more specific clinical assessments of anxiety
nd depression rather than relying solely on questionnaire
cores. Several variables were assessed by self report; thus, it
s possible that a more precise assessment of these factors
ay have affected the results. We were unable to assess all
f the potentially important pathophysiological mediators,
nd these may have accounted for additional unexplained
ariance. For example, dysregulation of the hypothalamic
ituitary adrenal axis, and altered hemodynamic and auto-
omic nervous system functioning have been implicated in
tress and CVD risk (1). The study has notable strengths,
ncluding the availability of clinically confirmed CVD
vents, the exclusion of participants with pre-existing CVD
t baseline, and the use of a nationally representative sample
rom Scotland. In summary, we have observed that patho-
hysiological and behavioral processes in particular partly
xplain the association between psychological distress and
VD events.
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